Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

New Outside Interests Disclosure Form

Case Western Reserve University is committed to ensuring its faculty an open and productive environment in which to conduct teaching and research. The institution's concern with conflict of interests reflects the ever-increasing complexity of our society, our various relations with each other and with outside institutions, along with the heightened national and governmental sensitivity to such matters.

University policy requires that all faculty and other researchers who contribute to scientific development disclose their outside interests at least annually. The 2014 Outside Interests disclosure process will begin the first week of February. The Office of Research Administration has transitioned to Click Sparta to administer the 2014 process. Sparta has had a positive impact on streamlining the pre-award system and by using specialized Sparta Conflict of Interests (COI) software we have created a much more user friendly COI system. Sparta COI will have the look and feel of Sparta which will ease transition to the new software.

Pertinent information that had been part of the Spiderweb disclosure process will not prepopulate the Sparta COI disclosure form, but any data disclosed in Sparta COI will remain to be updated or changed as the need arises.

A number of information sessions have been organized in February and March, and we hope you can join the Office of Research Administration COI staff for an opportunity to learn about the new Sparta COI software for the annual disclosure process. Attendees can stop in for a quick tutorial of the new system, or you can complete your disclosure during the session with assistance from the COI staff.

 
Diversity in Research

Tuesday, February 24, 2015
9:00 - 10:30 am
Biomedical Research Building, Room 105
4 CREC

Tuesday, April 7, 2015
2:00 3:30 pm
Biomedical Research Building, Room 105
4 CREC


Diversity in Research explores the scientific, ethical, and legal bases for the inclusion of diverse participants in research and the recruitment and hiring of diverse research staff. Potential barriers to diversity in the research context are discussed.

This workshop meets the requirements of the CWRU Office of Inclusion, Diversity, and Equal Opportunity (OIDEO) for participation on CWRU search committees.

Registration is online at: https://research.case.edu/Education/Onlinecalendar.cfm.

 
Case-Coulter Translational Research Partnership (CCTRP)

This is the fourth year of the second phase of the Case-Coulter Translational Research Partnership to support collaborative translational research projects that address unmet or poorly met clinical needs. The CCTRP seeks to reduce the market risk of promising new clinical products arising from the research programs of BME and other Case faculty. Successful projects will thus often focus on the development of prototype products, building relationships with companies, performing clinical feasibility studies, obtaining regulatory approval, and other activities that companies or business experts indicate are the essential last steps before a license can be negotiated or a startup launched. An overarching goal of the program is to foster research and development work likely leading to commercially relevant translational technologies within a three- to five-year horizon. Because the goals of all Coulter projects are to reduce market risk, all proposals are expected to reflect genuine business input, and all projects must include a “business advisor” as an important member of the decision making team.

Awards up to $200,000 will be considered if well justified.

Letter of Intent Deadline: February 13, 2015

For more information visit the BME website.

 

Foundation Fighting Blindness and Harrington Discovery Institute

Foundation Fighting Blindness and Harrington Discovery Institute have partnered to form, the The National Center for Excellence in Fighting Blindness, a Gund-Harrington initiative. This initiative is focused on accelerating the translation of research findings in inherited retinal degenerative diseases (IRD) with the ultimate goal of developing new therapies to improve and/or restore vision.

• This Initiative seeks to award Gund-Harrington Scholar Awards that recognize innovators throughout the USA whose research has the potential to advance standards of care.
• There will be an average of three awards per year, which will be restricted to researchers working at institutions within the USA. Applications from outside the USA are not accepted.
• The Gund-Harrington Scholar Award provides funding for translational drug development and cell therapy along with non-financial project support to help bridge the gap between laboratory-based research and the clinic.
• Funding up to a total of $900,000 over three years and non-financial support will be provided by the The National Center for Excellence in Fighting Blindness. The non-financial support, provided by a team of pharmaceutical experts, will include project management and experienced industry advice in all aspects of drug development, encompassing chemistry, formulation, toxicology, regulatory, intellectual property and business development.
• Awards will be made to physician-scientists, or scientists with a research team that includes significant involvement of a physician with clinical expertise in the IRD.
• Selected projects must demonstrate a reasonable expectation that they can develop a lead product with strong potential for clinical and commercial application by the end of the three year funding period.
Multi-disciplinary investigators outside the field of retinal disease are particularly encouraged to apply.

Applicants interested in the Gund-Harrington Scholar Awards must apply through Foundation Fighting Blindness.

For more information about Foundation Fighting Blindness visit the Fighting Blindness website.

 

CDC: Economic Studies of Immunization Policies and Practices

Funding Opportunity Number: RFA-IP-15-001

The purpose of this Funding Opportunity Announcement is to obtain economic information about vaccines and immunization policies, programs, and practices using economic and decision analyses and other appropriate methods. The results of these economic studies will be used to help inform policy and the development of effective interventions. Three studies will be conducted, including an analysis of the financial, economic, and epidemiologic relationships between vaccine-preventable infectious diseases and chronic diseases in adult populations, and the opportunity costs for immunization of failure to prevent chronic diseases. Study 1 may include, but need not be limited to influenza and pneumococcal diseases and diabetes. Study 2 will focus on an estimation of the costs of norovirus disease. Study three will involve an analysis of issues related to provider reimbursement for adult vaccination services.

Application Deadline: March 3, 2015

For more information visit the CDC’s Full Funding Opportunity Announcement.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.